Letter: Anti-epithelial antibodies and malignancy

The role of neuroendocrine cells in prostate cancer: a comprehensive review of current literature and subsequent rationale to broaden and integrate current treatment modalities.

Current medicinal chemistry·2013

The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues.

General physiology and biophysics·2000

The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female.

Histology and histopathology·2000

A tissue type transglutaminase in human seminal plasma.

American journal of reproductive immunology (New York, N.Y. : 1989)·1997

Sexual behaviour and increased anal cancer.

Immunology and cell biology·1997

A retrospective and prospective overview of prostate-specific antigen.

Journal of cancer research and clinical oncology·1997

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms.

Current hematologic malignancy reports·2026

Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia.

Journal of bone and mineral metabolism·2026

Cancer-associated pruritus: Insights into its pathogenesis and management.

The Journal of investigative dermatology·2026

Mechanisms underpinning the progression of nondysplastic Barrett's oesophagus to cancer.

The FEBS journal·2026

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Cancer investigation·2026

Malignant esophageal perforation with pleural empyema: a successful robotic esophagectomy with primary reconstruction - a case report.

International journal of surgery case reports·2026

Related Experiment Videos

Letter: Anti-epithelial antibodies and malignancy

Related Concept Videos

The role of neuroendocrine cells in prostate cancer: a comprehensive review of current literature and subsequent rationale to broaden and integrate current treatment modalities.

The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues.

The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female.

A tissue type transglutaminase in human seminal plasma.

Sexual behaviour and increased anal cancer.

A retrospective and prospective overview of prostate-specific antigen.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms.

Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia.

Cancer-associated pruritus: Insights into its pathogenesis and management.

Mechanisms underpinning the progression of nondysplastic Barrett's oesophagus to cancer.

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Malignant esophageal perforation with pleural empyema: a successful robotic esophagectomy with primary reconstruction - a case report.

Related Experiment Videos

Letter: Anti-epithelial antibodies and malignancy

Related Concept Videos

Related Articles